Lovenox 60 mg/.6mL (Enoxaparin Sodium INJECTION) 60 mg/.6mL

Lovenox 60 mg/0.6mL is an injectable medication containing enoxaparin sodium, used for various medical conditions. This subcutaneous injection is designed for convenient administration and is manufactured by Sanofi-Aventis U.S. LLC.

Strength

60 mg/.6mL

Pack Size

10 CELLO PACK in 1 CARTON (0075-8016-10) / 1 SYRINGE in 1 CELLO PACK / .6 mL in 1 SYRINGE (0075-801

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lovenox 60 mg/0.6mL is commonly used for anticoagulation therapy, helping to prevent blood clots. It is often prescribed for conditions like deep vein thrombosis, pulmonary embolism, and during certain surgical procedures. The medication works by thinning the blood, reducing the risk of clot formation. Patients may wonder, 'What is Lovenox used for?' and it is typically utilized in scenarios requiring blood thinning to prevent clotting.

Side Effects

Common effects of Lovenox 60 mg/0.6mL may include bruising, bleeding, or pain at the injection site. Some users might experience mild allergic reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Lovenox 60 mg/0.6mL should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow the prescribed dosage and administration guidelines. Patients with a history of bleeding disorders or allergies to enoxaparin sodium should exercise caution.

Avoid Interactions

Lovenox 60 mg/0.6mL may interact with other medications, particularly those that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also influence the medication's effectiveness.

Frequently Asked Questions

Lovenox 60 mg/0.6mL is used for anticoagulation therapy to prevent blood clots in various medical conditions.

Lovenox 60 mg/0.6mL is typically administered via subcutaneous injection, following the guidelines provided by a healthcare professional.

Common side effects may include bruising, bleeding, or pain at the injection site. Mild allergic reactions are also possible.

The use of Lovenox 60 mg/0.6mL during pregnancy should be discussed with a healthcare provider to weigh the benefits and risks.

Lovenox 60 mg/0.6mL should be stored as per the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.